After a healthy reset in 2016, biotech stock markets experienced a new wave of optimism with increased volumes...
Analysis of European Biotech Companies on the Stock Markets
The BIOCOM report “Analysis of European Biotech Companies on the Stock Markets: US vs Europe” provides a complete overview of the current European public biotech sector. Ever since 2012, it covers all IPOs, follow-on financings, and secondary listings on all major stock market centres in Europe, as well as on Nasdaq.
Download the report 2018/2 published in the European Biotechnology Magazine (PDF)
Do you want to know more? Are you ready to become part of the European biotech picture? Contact us now:
Latest Updates
Following a more cautious year 2016, the European public biotech sector observed an new increase of IPO and...
Biotech stocks in the US have recovered significantly in 2017. It corresponds with a number of successful...
Nearly a decade after the financial crisis, the European Life Science sector is flourishing again and has...
German pioneer in the field of immunotherapy
Berlin-based MOLOGEN AG is a pioneer for many reasons: Firstly,...
Share
